98 related articles for article (PubMed ID: 12017307)
1. Vitamin D receptor (VDR) expression is not a prognostic factor in cervical cancer.
Friedrich M; Meyberg R; Axt-Fliedner R; Villena-Heinsen C; Tilgen W; Schmidt W; Reichrath J
Anticancer Res; 2002; 22(1A):299-304. PubMed ID: 12017307
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor (VDR) expression is not a prognostic factor in breast cancer.
Friedrich M; Villena-Heinsen C; Tilgen W; Schmidt W; Reichrat J; Axt-Fliedner R
Anticancer Res; 2002; 22(3):1919-24. PubMed ID: 12168894
[TBL] [Abstract][Full Text] [Related]
3. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
Hellberg D; Tot T; Stendahl U
Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
[TBL] [Abstract][Full Text] [Related]
4. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma.
Villena-Heinsen C; Meyberg R; Axt-Fliedner R; Reitnauer K; Reichrath J; Friedrich M
Anticancer Res; 2002; 22(4):2261-7. PubMed ID: 12174912
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.
Holm R; Skomedal H; Helland A; Kristensen G; Børresen AL; Nesland JM
J Pathol; 1993 Jan; 169(1):21-6. PubMed ID: 8433212
[TBL] [Abstract][Full Text] [Related]
9. The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma.
Santin AD; Cane' S; Bellone S; Bignotti E; Palmieri M; De Las Casas LE; Anfossi S; Roman JJ; O'Brien T; Pecorelli S
Cancer; 2003 Nov; 98(9):1898-904. PubMed ID: 14584072
[TBL] [Abstract][Full Text] [Related]
10. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
[TBL] [Abstract][Full Text] [Related]
11. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
[TBL] [Abstract][Full Text] [Related]
15. Gene expression in early stage cervical cancer.
Biewenga P; Buist MR; Moerland PD; Ver Loren van Themaat E; van Kampen AH; ten Kate FJ; Baas F
Gynecol Oncol; 2008 Mar; 108(3):520-6. PubMed ID: 18191186
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
Chen TP; Chen CM; Chang HW; Wang JS; Chang WC; Hsu SI; Cho CL
Gynecol Oncol; 2007 Mar; 104(3):516-23. PubMed ID: 17079005
[TBL] [Abstract][Full Text] [Related]
17. The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.
Cané S; Bignotti E; Bellone S; Palmieri M; De las Casas L; Roman JJ; Pecorelli S; Cannon MJ; O'brien T; Santin AD
Am J Obstet Gynecol; 2004 Jan; 190(1):60-6. PubMed ID: 14749636
[TBL] [Abstract][Full Text] [Related]
18. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis].
Wu SH; Zhang J; Li Y; Li JM
Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
Wang PH; Ko JL; Tsai HT; Yang SF; Han CP; Lin LY; Chen GD
Gynecol Oncol; 2008 Mar; 108(3):533-42. PubMed ID: 18177928
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
